Navigation Links
Muscle-targeted gene therapy reverses rare muscular dystrophy in mice

Gene therapy methods that specifically target muscle may reverse the symptoms of a rare form of muscular dystrophy, according to new research in mice conducted by medical geneticists at Duke University Medical Center. Infants born with the inherited muscular disorder called Pompe disease usually die before they reach the age of two. The researchers also said their approach of targeting corrective genes to muscles may have application in treating other muscular dystrophies.

Patients with Pompe disease have a defect in a key enzyme that converts glycogen, a stored form of sugar, into glucose, the body's primary energy source. As a result, glycogen builds up in muscles throughout the body, including the heart, causing muscles to degenerate.

Using genetically altered mice in which the gene for the enzyme had been rendered nonfunctional, the researchers demonstrated they could introduce the functioning gene and correct glycogen buildup in heart and skeletal muscle. The findings suggest that such an approach should be considered as a potential gene therapy strategy for Pompe disease patients, the researchers report in a forthcoming issue of Molecular Therapy (now available online).

"Gene therapy in muscular dystrophies presents a unique challenge, because replacement of deficient, therapeutic proteins invokes an immune response that limits the efficacy of the treatment," said Duke medical geneticist Dwight Koeberl, M.D., senior author of the study. "By restricting the expression of introduced genes to muscle, the immune response can be prevented or attenuated."

The muscle-targeted gene therapy might therefore apply to other forms of muscular dystrophy, they added. Muscular dystrophies include many genetic diseases, all of which are characterized by progressive weakness and degeneration of the skeletal muscles which control movement.

The Muscular Dystrophy Association and Genzyme Corporation supported the research.

Several for
'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Columbia research lifts major hurdle to gene therapy for cancer
3. Combination therapy boosts effectiveness of telomere-directed cancer cell death
4. Gene therapy converts dead bone graft to new, living tissue
5. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
6. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
7. New therapy for HIV/AIDS eliminates needles and excessive toxicity
8. New Treatment Rivals Chemotherapy For Lymphoma, Study Finds
9. Gene therapy for Parkinsons disease moves forward in animals
10. Pulsating ultrasound enhances gene therapy for tumors
11. Antiretroviral therapy may prevent excess risk of some cancers in people with HIV

Post Your Comments:
(Date:11/3/2009)...November 4, 2009) For more than 25 years, all att...trombus gigas ) have been unsuccessfuluntil now. F...echniques to produce beaded (nucleated) and non-be...n developed by scientists from Florida Atlantic Un...HBOI). With less than two years of research and ex...
(Date:11/3/2009)...ser labeling of fruit and vegetables is a new, pat...ide laser beam is used to label, or "etch" informa...common sticker-type labels. The technology has bee...tables and is being used in New Zealand, Australia...oved in Asia, South Africa, Central and South Amer...
(Date:11/3/2009)...UCLA Henry Samueli School of Engineering and Appli...constituted in the laboratory the enzyme responsib...ing drug lovastatin. , The research, publishe...lly lead to the development of other compounds wit...tin-synthesizing enzyme is one of the most interes...
Breaking Biology News(10 mins):Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Laser etching safe alternative for labeling grapefruit 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2MicroRNAs help control HIV life cycle 9008 1MicroRNAs help control HIV life cycle 9008 2University of Maryland Company Trauma Solutions Named Finalist in 24250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 50088 1University of Maryland Company Trauma Solutions Named Finalist in 24250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 50088 2University of Maryland Company Trauma Solutions Named Finalist in 24250K Draper Fisher Jurvetson and Cisco Systems Global Business Plan Competition 50088 3Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution 50085 1Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution 50085 2Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution 50085 3Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution 50085 4Diagnostic Center of Medicine Selects Allscripts Electronic Health Record and Practice Management Solution 50085 5
...Ore. Can a patient-centered, care management prog...inary teams, supported by electronic tracking and ...s and hospitalizations among chronically ill older...involving more than 3,400 chronically ill seniors ...er David A. Dorr, M.D. appears to be "yes." , Th...
...erson who reminds you to floss might be your cardi...nown for some time that a protein associated with ...o are at risk for heart disease. But where,s the i...talian and U.K. scientists published online in Th...ne place. Indeed, proper dental hygiene should red...
...Dec. 15, 2008) -- In the aftermath of a heart atta...re heart failure. Authors of a new study believe t...ant role in a process that replaces dead heart mus...re hopeful that the findings will lead to the deve... "The body tries to fix the injury to the heart m...
Other Biology News:Proactive care saves lives of seniors, study finds 2Proactive care saves lives of seniors, study finds 3Reducing the damage of a heart attack 2
(Date:11/5/2009)... 5 BioSpecifics Technolo...ompany developing first-in-class collagenase-based...or the third quarter ended September 30, 2009. ,... this year, the FDA,s Arthritis Advisory Committee...pproval of XIAFLEX(TM) for the treatment of Dupuyt...
(Date:11/5/2009)...ov. 5 Wound Management T... has entered into a Letter of Intent to purchase a...hnologies, Inc. (OTC Bulletin Board: VHGI). The de... and debt, 4,000,000 shares of WNDM and a royalty ...riscrip technology being acquired from VHGI. WND...
(Date:11/5/2009).... 5 WaferGen Biosystems,...per of state-of-the-art genetic analysis systems, ...joined the company,s Scientific Advisory Board. H...cializing novel molecular diagnostics for cancer d...pment of computational biology systems for several...
(Date:11/5/2009)..., Pa., Nov. 5 /PRNewswire-Asia-FirstCall/ -- BMP S...e" or the "Company") today announced,that the Comp...results on,Monday, November 9, 2009, after the mar...ference call at 5:00 pm ET on November 9, 2009,to ... access the call by,dialing 1-888-713-4211 or 1-61...
Breaking Biology Technology:BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 2OTCBB-WNDM Announces LOI to Acquire VHGI Assets for $10 Million Cash/Stock 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 2WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 3WaferGen Names Christopher Sears, Ph.D., Architect of High-Value Molecular Diagnostics and Computational Biology Platforms, to Company's Scientific Advisory Board 4BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...S, N.J., Nov. 16 Genta,Incorporated (Nasdaq: GNT...nation letter from the NASDAQ Stock Market stating...isting from The NASDAQ Global,Market because the C...ntain,a minimum $10,000,000 value in stockholders,...3). The Company intends to provide a plan to,NASDA...
...t has led in the discovery of genes that confer ri... to explore their own genome W..., Nov. 16 deCODE genetics,(Nasdaq: DCGN ) today ...,service that enables individuals to get a detaile...tion to deCODEme(TM), you can learn what your DNA,...
.... 15 /PRNewswire-FirstCall/ - Helix BioPharma Corp...es for Dr. Donald Segal and,John Docherty. Effecti...Officer and President formerly held by Dr. Segal w... Company,s Chief Executive Officer and Mr.,Dochert...es are being made as we strive to expand our corpo...
Other Biology Technology:Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 2Genta Receives Notice of Non-Compliance with Listing Requirement for NASDAQ Global Market 3deCODE Launches deCODEme(TM) 2deCODE Launches deCODEme(TM) 3deCODE Launches deCODEme(TM) 4Helix BioPharma Corp. announces management changes 2
DNP-X acid, SE -- [6-(2,4-Dinitrophenyl)aminohexanoic acid, succinimidyl ester] from AnaSpec
Mouse Anti-Laminin beta-2 Monoclonal Antibody, Unconjugated, Clone C4 from Santa Cruz Biotechnology, Inc.
Rabbit Anti-ZO-2 (H-110) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Goat Anti-TNFalpha-IP 2 (G-17) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: